These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 10940226)

  • 1. Chelation and intercalation: complementary properties in a compound for the treatment of Alzheimer's disease.
    Cherny RA; Barnham KJ; Lynch T; Volitakis I; Li QX; McLean CA; Multhaup G; Beyreuther K; Tanzi RE; Masters CL; Bush AI
    J Struct Biol; 2000 Jun; 130(2-3):209-16. PubMed ID: 10940226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, selection, and characterization of thioflavin-based intercalation compounds with metal chelating properties for application in Alzheimer's disease.
    Rodríguez-Rodríguez C; Sánchez de Groot N; Rimola A; Alvarez-Larena A; Lloveras V; Vidal-Gancedo J; Ventura S; Vendrell J; Sodupe M; González-Duarte P
    J Am Chem Soc; 2009 Feb; 131(4):1436-51. PubMed ID: 19133767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of clioquinol on metal-triggered amyloid-beta aggregation revisited.
    Mancino AM; Hindo SS; Kochi A; Lim MH
    Inorg Chem; 2009 Oct; 48(20):9596-8. PubMed ID: 19817493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NMR reveals anomalous copper(II) binding to the amyloid Abeta peptide of Alzheimer's disease.
    Hou L; Zagorski MG
    J Am Chem Soc; 2006 Jul; 128(29):9260-1. PubMed ID: 16848423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of zinc(II) and copper(II) to the full-length Alzheimer's amyloid-beta peptide.
    Tõugu V; Karafin A; Palumaa P
    J Neurochem; 2008 Mar; 104(5):1249-59. PubMed ID: 18289347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The lipophilic metal chelator DP-109 reduces amyloid pathology in brains of human beta-amyloid precursor protein transgenic mice.
    Lee JY; Friedman JE; Angel I; Kozak A; Koh JY
    Neurobiol Aging; 2004; 25(10):1315-21. PubMed ID: 15465629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of copper binding to the peptide amyloid-beta(1-16) associated with Alzheimer's disease.
    Ma QF; Hu J; Wu WH; Liu HD; Du JT; Fu Y; Wu YW; Lei P; Zhao YF; Li YM
    Biopolymers; 2006 Sep; 83(1):20-31. PubMed ID: 16615111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copper complexing decreases the ability of amyloid beta peptide to cross the BBB and enter brain parenchyma.
    Mare S; Penugonda S; Robinson SM; Dohgu S; Banks WA; Ercal N
    Peptides; 2007 Jul; 28(7):1424-32. PubMed ID: 17580097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterizing bathocuproine self-association and subsequent binding to Alzheimer's disease amyloid beta-peptide by NMR.
    Yao S; Cherny RA; Bush AI; Masters CL; Barnham KJ
    J Pept Sci; 2004 Apr; 10(4):210-7. PubMed ID: 15119593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copper and zinc binding to amyloid-beta: coordination, dynamics, aggregation, reactivity and metal-ion transfer.
    Faller P
    Chembiochem; 2009 Dec; 10(18):2837-45. PubMed ID: 19877000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two pyridine derivatives as potential Cu(II) and Zn(II) chelators in therapy for Alzheimer's disease.
    Lakatos A; Zsigó E; Hollender D; Nagy NV; Fülöp L; Simon D; Bozsó Z; Kiss T
    Dalton Trans; 2010 Feb; 39(5):1302-15. PubMed ID: 20104357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel D-penicillamine carrying nanoparticles for metal chelation therapy in Alzheimer's and other CNS diseases.
    Cui Z; Lockman PR; Atwood CS; Hsu CH; Gupte A; Allen DD; Mumper RJ
    Eur J Pharm Biopharm; 2005 Feb; 59(2):263-72. PubMed ID: 15661498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta.
    Adlard PA; Cherny RA; Finkelstein DI; Gautier E; Robb E; Cortes M; Volitakis I; Liu X; Smith JP; Perez K; Laughton K; Li QX; Charman SA; Nicolazzo JA; Wilkins S; Deleva K; Lynch T; Kok G; Ritchie CW; Tanzi RE; Cappai R; Masters CL; Barnham KJ; Bush AI
    Neuron; 2008 Jul; 59(1):43-55. PubMed ID: 18614028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metal ions differentially influence the aggregation and deposition of Alzheimer's beta-amyloid on a solid template.
    Ha C; Ryu J; Park CB
    Biochemistry; 2007 May; 46(20):6118-25. PubMed ID: 17455909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioiodinated clioquinol as a biomarker for beta-amyloid: Zn complexes in Alzheimer's disease.
    Opazo C; Luza S; Villemagne VL; Volitakis I; Rowe C; Barnham KJ; Strozyk D; Masters CL; Cherny RA; Bush AI
    Aging Cell; 2006 Feb; 5(1):69-79. PubMed ID: 16441845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary studies of a novel bifunctional metal chelator targeting Alzheimer's amyloidogenesis.
    Dedeoglu A; Cormier K; Payton S; Tseitlin KA; Kremsky JN; Lai L; Li X; Moir RD; Tanzi RE; Bush AI; Kowall NW; Rogers JT; Huang X
    Exp Gerontol; 2004; 39(11-12):1641-9. PubMed ID: 15582280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular modeling of zinc and copper binding with Alzheimer's amyloid beta-peptide.
    Han D; Wang H; Yang P
    Biometals; 2008 Apr; 21(2):189-96. PubMed ID: 17629774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aging, gender and APOE isotype modulate metabolism of Alzheimer's Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits.
    Yao J; Petanceska SS; Montine TJ; Holtzman DM; Schmidt SD; Parker CA; Callahan MJ; Lipinski WJ; Bisgaier CL; Turner BA; Nixon RA; Martins RN; Ouimet C; Smith JD; Davies P; Laska E; Ehrlich ME; Walker LC; Mathews PM; Gandy S
    J Neurochem; 2004 Aug; 90(4):1011-8. PubMed ID: 15287908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective destabilization of soluble amyloid beta oligomers by divalent metal ions.
    Garai K; Sengupta P; Sahoo B; Maiti S
    Biochem Biophys Res Commun; 2006 Jun; 345(1):210-5. PubMed ID: 16678130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, characterization, and metal coordinating ability of multifunctional carbohydrate-containing compounds for Alzheimer's therapy.
    Storr T; Merkel M; Song-Zhao GX; Scott LE; Green DE; Bowen ML; Thompson KH; Patrick BO; Schugar HJ; Orvig C
    J Am Chem Soc; 2007 Jun; 129(23):7453-63. PubMed ID: 17511455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.